Cargando…
The role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia
Eltrombopag is a 2nd generation thrombopoietin-receptor agonist. It binds with the thrombopoietin-receptors found on the surfaces of the megakaryocytes & increases platelet production. Many recent studies have suggested a potential role for this novel agent in the treatment of thrombocytopenia a...
Autores principales: | Danish, Fazal-i-Akbar, Yasmin, Saeeda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3953736/ https://www.ncbi.nlm.nih.gov/pubmed/24696622 http://dx.doi.org/10.2147/HMER.S27100 |
Ejemplares similares
-
Considerations in the Management of Hepatitis C Virus-related Thrombocytopenia with Eltrombopag
por: Danish, Fazal A., et al.
Publicado: (2010) -
Predictors for eltrombopag response in patients with hepatitis C virus-associated thrombocytopenia
por: Elbedewy, Tamer A, et al.
Publicado: (2019) -
Role of Hematopoietic Growth Factors as Adjuncts in the Treatment of Chronic Hepatitis C Patients
por: Danish, Fazal A., et al.
Publicado: (2008) -
Eltrombopag in long‐term management of pediatric thrombocytopenia
por: Shah, Sanjay J., et al.
Publicado: (2018) -
Resistant thrombocytopenia in an HIV and hepatitis C patient: treatment response with novel agent eltrombopag
por: Vijayakrishnan, Rajakrishnan, et al.
Publicado: (2011)